Publicaciones (22) Publicaciones en las que ha participado algún/a investigador/a

2010

  1. Adjuvant docetaxel for high-risk, node-negative breast cancer

    New England Journal of Medicine, Vol. 363, Núm. 23, pp. 2200-2210

  2. Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: A prospective analysis of axillary or distant recurrence

    Annals of Surgical Oncology, Vol. 17, Núm. 3, pp. 772-777

  3. Biological reprogramming in acquired resistance to endocrine therapy of breast cancer

    Oncogene, Vol. 29, Núm. 45, pp. 6071-6083

  4. Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients

    Lung Cancer, Vol. 68, Núm. 3, pp. 491-497

  5. Construyendo un aprendizaje cooperativo e integrador. Experiencia de innovación docente en el marco del EEES

    Metas de enfermería, Vol. 13, Núm. 1, pp. 50-55

  6. Current controversies in the management of breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286

  7. Current perspectives of treatment of ductal carcinoma in situ

    Cancer Treatment Reviews, Vol. 36, Núm. 7, pp. 507-517

  8. Cáncer de ovario. Enfermedad platino sensible

    Revisiones en Cancer, Vol. 24, Núm. 6, pp. 245-252

  9. Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))

    Clinical and Translational Oncology

  10. Evaluation of immunoassays as an alternative for the rapid determination of pesticides in wine and grape samples

    Journal of AOAC International, Vol. 93, Núm. 1, pp. 2-11

  11. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma

    Tumori, Vol. 96, Núm. 3, pp. 405-410

  12. Hidromorfona: Una alternativa en el tratamiento del dolor

    Revista de la Sociedad Espanola del Dolor, Vol. 17, Núm. 3, pp. 153-161

  13. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)

    Annals of Oncology, Vol. 21, Núm. 9, pp. 1794-1803

  14. Intervención farmacéutica en gestante. Derivación al médico para modificar la posición del feto

    Farmacéuticos comunitarios, Vol. 2, Núm. 2, pp. 74-75

  15. Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer

    Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 149-157

  16. Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer

    Annals of the New York Academy of Sciences, Vol. 1210, Núm. 1, pp. 86-92

  17. Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer

    Clinical Lung Cancer, Vol. 11, Núm. 2, pp. 105-113

  18. Positive sentinel node risk in relation to oestrogen receptors in breast cancer in premenopausal and postmenopausal women

    Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 6, pp. 289-292

  19. Recent advances in cancer therapy: An overview

    Current Pharmaceutical Design, Vol. 16, Núm. 1, pp. 3-10

  20. SEOM clinical guidelines for the treatment of metastatic breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 719-723